For example, ZEB1 promotes tumorigenesis and metastasis in HCC by facilitating the Warburg effect through transcriptional activation of PFKM.4 Knockdown of FOXK1 hinders liver cancer cell activity by suppressing glycolysis.5 Hence, targeting glycolytic metabolic pathways could proffer a fresh therapeutic strategy for liver cancer. This evidence concerns the gene ZEB1 and liver cancer.